221 related articles for article (PubMed ID: 35007407)
21. Cellular mechanisms and treatments for chemobrain: insight from aging and neurodegenerative diseases.
Nguyen LD; Ehrlich BE
EMBO Mol Med; 2020 Jun; 12(6):e12075. PubMed ID: 32346964
[TBL] [Abstract][Full Text] [Related]
22. Protective Effect of a Mitochondria-Targeted Peptide against the Development of Chemotherapy-Induced Peripheral Neuropathy in Mice.
Toyama S; Shimoyama N; Szeto HH; Schiller PW; Shimoyama M
ACS Chem Neurosci; 2018 Jul; 9(7):1566-1571. PubMed ID: 29660270
[TBL] [Abstract][Full Text] [Related]
23. Crosstalk between anticancer drugs and mitochondrial functions.
Sahu K; Langeh U; Singh C; Singh A
Curr Res Pharmacol Drug Discov; 2021; 2():100047. PubMed ID: 34909674
[TBL] [Abstract][Full Text] [Related]
24. Doxorubicin and cisplatin induced cognitive impairment: The possible mechanisms and interventions.
Ongnok B; Chattipakorn N; Chattipakorn SC
Exp Neurol; 2020 Feb; 324():113118. PubMed ID: 31756316
[TBL] [Abstract][Full Text] [Related]
25. Role of Mitochondrial Mechanism in Chemotherapy-Induced Peripheral Neuropathy.
Waseem M; Kaushik P; Tabassum H; Parvez S
Curr Drug Metab; 2018; 19(1):47-54. PubMed ID: 29219049
[TBL] [Abstract][Full Text] [Related]
26. CD8+ T Cells and Endogenous IL-10 Are Required for Resolution of Chemotherapy-Induced Neuropathic Pain.
Krukowski K; Eijkelkamp N; Laumet G; Hack CE; Li Y; Dougherty PM; Heijnen CJ; Kavelaars A
J Neurosci; 2016 Oct; 36(43):11074-11083. PubMed ID: 27798187
[TBL] [Abstract][Full Text] [Related]
27. Nasal administration of mesenchymal stem cells prevents accelerated age-related tauopathy after chemotherapy in mice.
Zamorano M; Alexander JF; Catania D; Dharmaraj S; Kavelaars A; Heijnen CJ
Immun Ageing; 2023 Jan; 20(1):5. PubMed ID: 36698170
[TBL] [Abstract][Full Text] [Related]
28. Platin-
Banik B; Ashokan A; Choi JH; Surnar B; Dhar S
Dalton Trans; 2023 Mar; 52(12):3575-3585. PubMed ID: 36723189
[TBL] [Abstract][Full Text] [Related]
29. Melatonin and metformin counteract cognitive dysfunction equally in male rats with doxorubicin-induced chemobrain.
Chunchai T; Pintana H; Arinno A; Ongnok B; Pantiya P; Khuanjing T; Prathumsap N; Maneechote C; Chattipakorn N; Chattipakorn SC
Neurotoxicology; 2023 Jan; 94():158-171. PubMed ID: 36463981
[TBL] [Abstract][Full Text] [Related]
30. Precisely Assembled Nanoparticles against Cisplatin Resistance via Cancer-Specific Targeting of Mitochondria and Imaging-Guided Chemo-Photothermal Therapy.
Yang GG; Pan ZY; Zhang DY; Cao Q; Ji LN; Mao ZW
ACS Appl Mater Interfaces; 2020 Sep; 12(39):43444-43455. PubMed ID: 32883070
[TBL] [Abstract][Full Text] [Related]
31. Pharmacological rescue of cognitive function in a mouse model of chemobrain.
Nguyen LD; Fischer TT; Ehrlich BE
Mol Neurodegener; 2021 Jun; 16(1):41. PubMed ID: 34174909
[TBL] [Abstract][Full Text] [Related]
32. Cisplatin educates CD8+ T cells to prevent and resolve chemotherapy-induced peripheral neuropathy in mice.
Laumet G; Edralin JD; Dantzer R; Heijnen CJ; Kavelaars A
Pain; 2019 Jun; 160(6):1459-1468. PubMed ID: 30720585
[TBL] [Abstract][Full Text] [Related]
33. Cisplatin Toxicity in Dorsal Root Ganglion Neurons Is Relieved by Meclizine via Diminution of Mitochondrial Compromise and Improved Clearance of DNA Damage.
Gorgun MF; Zhuo M; Englander EW
Mol Neurobiol; 2017 Dec; 54(10):7883-7895. PubMed ID: 27858292
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of Mitochondrial p53 Accumulation by PFT-μ Prevents Cisplatin-Induced Peripheral Neuropathy.
Maj MA; Ma J; Krukowski KN; Kavelaars A; Heijnen CJ
Front Mol Neurosci; 2017; 10():108. PubMed ID: 28458631
[TBL] [Abstract][Full Text] [Related]
35. [Chemobrain - cognitive disorders after chemotherapy].
Kupryjaniuk A; Sobstyl M
Pol Merkur Lekarski; 2022 Dec; 50(300):398-400. PubMed ID: 36645690
[TBL] [Abstract][Full Text] [Related]
36. Pharmacogenomics of cisplatin-induced neurotoxicities: Hearing loss, tinnitus, and peripheral sensory neuropathy.
Zhang X; Trendowski MR; Wilkinson E; Shahbazi M; Dinh PC; Shuey MM; ; Feldman DR; Hamilton RJ; Vaughn DJ; Fung C; Kollmannsberger C; Huddart R; Martin NE; Sanchez VA; Frisina RD; Einhorn LH; Cox NJ; Travis LB; Dolan ME
Cancer Med; 2022 Jul; 11(14):2801-2816. PubMed ID: 35322580
[TBL] [Abstract][Full Text] [Related]
37. Nose-to-brain Drug Delivery System: An Emerging Approach to Chemotherapy-induced Cognitive Impairment.
Reddy SJ; Mutalik S; Viswanatha GL; Kumar G; John J; Chamallamudi MR; Das A; Das S; Nandakumar K
Pharm Nanotechnol; 2024 May; ():. PubMed ID: 38757164
[TBL] [Abstract][Full Text] [Related]
38. Neuroinflammatory Process Involved in Different Preclinical Models of Chemotherapy-Induced Peripheral Neuropathy.
Fumagalli G; Monza L; Cavaletti G; Rigolio R; Meregalli C
Front Immunol; 2020; 11():626687. PubMed ID: 33613570
[TBL] [Abstract][Full Text] [Related]
39. Chemotherapy-Induced Peripheral Neuropathy in Long-term Survivors of Childhood Cancer: Clinical, Neurophysiological, Functional, and Patient-Reported Outcomes.
Kandula T; Farrar MA; Cohn RJ; Mizrahi D; Carey K; Johnston K; Kiernan MC; Krishnan AV; Park SB
JAMA Neurol; 2018 Aug; 75(8):980-988. PubMed ID: 29799906
[TBL] [Abstract][Full Text] [Related]
40. Impact of aging on meningeal gene expression.
Neutzner M; Kohler C; Frank S; Killer HE; Neutzner A
Fluids Barriers CNS; 2023 Feb; 20(1):12. PubMed ID: 36747230
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
